PharmaShots | Incisive News in 3 Shots

Subscribe Now

Monotherapy Treatment

GSK's Blenrep (belantamab mafodotin-blmf) Receives the US FDA's Approval as a Monotherapy Treatment for Multiple Myeloma

GSK's Blenrep (belantamab mafodotin-blmf) Receives the US FDA's Approval as a Monotherapy Treatment for Multiple Myeloma

August 6, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us